﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>10</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2020</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Comparative impact of platelet rich plasma and transforming growth factor-β on chondrogenic differentiation of human adipose derived stem cells</ArticleTitle>
    <FirstPage>37</FirstPage>
    <LastPage>43</LastPage>
    <ELocationID EIdType="doi">10.15171/bi.2020.05</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Roya</FirstName>
        <LastName>Hesari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4315-3309</Identifier>
      </Author>
      <Author>
        <FirstName>Mina</FirstName>
        <LastName>Keshvarinia</LastName>
      </Author>
      <Author>
        <FirstName>Mahboubeh</FirstName>
        <LastName>Kabiri</LastName>
      </Author>
      <Author>
        <FirstName>Iman</FirstName>
        <LastName>Rad</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7185-6629</Identifier>
      </Author>
      <Author>
        <FirstName>Kazem</FirstName>
        <LastName>Parivar</LastName>
      </Author>
      <Author>
        <FirstName>Hoorieh</FirstName>
        <LastName>Hoseinpoor</LastName>
      </Author>
      <Author>
        <FirstName>Rezvan</FirstName>
        <LastName>Tavakoli</LastName>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Soleimani</LastName>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Kouhkan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7262-0207</Identifier>
      </Author>
      <Author>
        <FirstName>Soheila</FirstName>
        <LastName>Zamanluee</LastName>
      </Author>
      <Author>
        <FirstName>Hana</FirstName>
        <LastName>Hanaee-Ahvaz</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9249-4279</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/bi.2020.05</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>08</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>10</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Transforming growth factor-beta (TGF-β) is known as standard chondrogenic differentiation agent, even though it comes with undesirable side effects such as early hypertrophic maturation, mineralization, and secretion of inflammatory/angiogenic factors. On the other hand, platelet-rich plasma (PRP) is found to have a chondrogenic impact on mesenchymal stem cell proliferation and differentiation, with no considerable side effects. Therefore, we compared chondrogenic impact of TGF-β and PRP on adipose-derived stem cells (ADSCs), to see if PRP could be introduced as an alternative to TGF-β. Methods: Differentiation of ADSCs was monitored using a couple of methods including glycosaminoglycan production, miRNAs expression, vascular endothelial growth factor (VEGF)/tumor necrosis factor alpha (TNFα) secretion, alkaline phosphatase (ALP) and calcium content assays.  Results: Accordingly, the treatment of differentiating cells with 5% (v/v) PRP resulted in higher glycosaminoglycan production, enhanced SOX9 transcription, and lowered TNFα and VEGF secretion compared to the control and TGF-β groups. Besides, the application of PRP to the media up-regulated miR-146a and miR-199a in early and late stages of chondrogenesis, respectively.  Conclusion: PRP induces in vitro chondrogenesis, as well as TGF-β with lesser inflammatory and hypertrophic side effects.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Calcium deposition</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chondrogenesis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Transforming growth factor-beta</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Platelet rich plasma</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>